Home Search
COVID-19 - search results
If you're not happy with the results, please do another search
Sputnik V vaccine is 91.6% effective against COVID
Interim data from Phase 3 clinical trials show that Russia's Sputnik V vaccine is capable of a 91.6% efficacy against COVID-19.
Coronavirus-related business interruption insurance claims
Jade Brooks, an associate solicitor at Blaser Mills Law, responds to The Supreme Court’s ruling on coronavirus-related business interruption insurance claims and discusses what it means for policyholders.
Data shows young, Black adults twice as likely to die after heart transplant
The American Heart Association found that young, Black adults are more than twice as likely to die in the first year after a heart transplant - in comparison to non-Black transplant recipients of the same age.
How to handle vaccine hesitancy at work
Alan Price, CEO at BrightHR, discusses how employers and HR departments can handle vaccine hesitancy in the workplace.
All UK adults could be offered COVID vaccine by May
According to recent reports, all UK adults could have their first dose of the COVID vaccine by May, 2021 - opening up the potential of a real summer.
High infection numbers can undo our vaccination programmes
The vaccine roll out gives hope of a return to some form of normality, but current high COVID-19 infection numbers put the success of vaccination programmes at risk. Professor Martin Michaelis and Dr Mark Wass of University of Kent’s School of Biosciences explain why.
UK Government allocates £50 million to support students during pandemic
The UK Government has allocated an additional £50 million to support students facing financial pressures from the pandemic.
UK purchases additional 40 million doses of Valneva vaccine
The UK government has announced that it has secured early access to a further 40 million doses of the Valneva COVID-19 vaccine.
Johnson & Johnson vaccine has 66% efficiency in one dose
New clinical trial data shows that the Johnson & Johnson vaccine is able to give 66% protection against COVID in one dose - with an 85% efficiency at the standard double-dose.
Three ways to solve the logistical challenges of giving COVID vaccines
An anonymous Doctor explains their ideas for how the NHS could tackle the significant logistical challenges of giving COVID vaccines.
Horizon Europe reveals five main missions for new funding
The new Horizon Europe programme will pick up where Horizon 2020 left off, with five main missions - cancer, climate change, marine environment, smart cities and food security.
Novavax vaccine is 85.6% efficient against UK COVID mutation
Phase Three data from the UK trial shows that Novavax still works powerfully against the UK mutation, with a less intense impact on the South African mutation at 60%.
Green aviation projects to receive £84 million funding boost
Three projects have been awarded £84 million from the Aerospace Technology Institute (ATI) programme to power zero-emissions flights .
AI technology can help tackle the cancer care backlog
Hugh Bettesworth, CEO, Mirada Medical, explores how AI autocontouring technology can help tackle the cancer care backlog as a result of the COVID-19 pandemic.
President Biden signs bundle of executive orders on climate change
Yesterday, President Biden signed a slew of executive orders on climate change, describing the new proposals as a way to fight an "existential threat".
CCS and NHS digital launch Digital Capability for Health framework
Crown Commercial Service's have announced that there new Digital Capability for Health framework in collaboration with NHS Digital is now live.
Engineers design model for using one ventilator on two patients
Engineers at the University of Bath have published a mathematical model that could help clinicians to safely ventilate two COVID patients on one ventilator.
Is this a vaccine war or the first post-Brexit war?
Right now, the rift between AstraZeneca and the European Commission continues to grow - but is it a vaccine war or the first post-Brexit war?
The plastic timeline: How did we get here?
Using statistics from Statista, Loadhog analysed data on global plastic production from 1950 to 2018 alongside global population figures and new laws to show exactly where we are in terms of our use of plastic.
REACT study: UK scientists aren’t seeing a “sharp drop in infections”
New data from the REACT study finds that the rising infection rate has steadied a little, but there is no "sharp drop in infections" as in the first wave and the R is still high.